The effect of hexanic extract of Serenoa repens on prostatic inflammation: results from a randomized biopsy study
Συγγραφέας
Gravas S., Samarinas M., Zacharouli K., Karatzas A., Tzortzis V., Koukoulis G., Melekos M.Ημερομηνία
2019Γλώσσα
en
Λέξη-κλειδί
Επιτομή
Purpose: To evaluate the effect of hexanic extract of Serenoa repens (HESr) on prostatic inflammation in patients with diagnosed prostatic inflammation. Methods: Patients with prostatic inflammation histologically confirmed by TRUS prostatic biopsy were randomized either to receive HESr (320 mg/day) or no treatment. A second biopsy was performed 6 months later according to standard clinical practice. Inflammation was assessed by the Irani’s score and immunohistochemical staining using the CD3, CD4 and CD8 (for T-leucocytes), CD20 (for B-leucocytes) and CD163 (for macrophages) antibodies. Results: Overall 97 patients were eligible for analysis. In the HESr group the mean inflammation grading and aggressiveness grading score significantly decreased from 1.55 and 1.55 at baseline to 0.79 (p = 0.001) and 0.87 (p = 0.001) at the second biopsy, respectively. In the control group the mean inflammation grading score was 1.44 at first biopsy and 1.23 at the second biopsy. The mean aggressiveness gradings core was 1.09 and 0.89, respectively. No statistical significance was found (p = 0.09 and p = 0.74).The mean decrease in all inflammation scores was statistically higher in the HESr patients compared to controls. The immunohistochemical staining showed a significant change in the expression of the analyzed antibodies for the HESr patients compared to the first biopsy. In the nontreatment group, no significant difference was found at the second biopsy. The change in expression of each antibody in the HESr group was statistical significant compared to control. Conclusions: HESr seems to reduce prostatic inflammation in terms of histological and immunohistochemical parameters in this specific patients population. © 2018, Springer-Verlag GmbH Germany, part of Springer Nature.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Myeloid-derived suppressor cells in prostate cancer: Present knowledge and future perspectives
Koinis F., Xagara A., Chantzara E., Leontopoulou V., Aidarinis C., Kotsakis A. (2022)Several lines of research are being investigated to better understand mechanisms implicated in response or resistance to immune checkpoint blockade in prostate cancer (PCa). Myeloid-derived suppressor cells (MDSCs) have ... -
Delphinidin diminishes in vitro interferon-γ and interleukin-17 producing cells in patients with psoriatic disease
Tsiogkas S.G., Mavropoulos Α., Skyvalidas D.N., Patrikiou E., Ntavari N., Daponte A.I., Grammatikopoulou M.G., Dardiotis E., Roussaki-Schulze A.-V., Sakkas L.I., Zafiriou E., Bogdanos D.P. (2022)The anthocyanidin delphinidin reduces psoriasiform lesions and inflammatory mediators in human cell culture systems. Its role in psoriatic disease has not yet been investigated. We assessed delphinidin’s in vitro ... -
Patient with prostatic adenocarcinoma with plasmacytoid features and an aberrant immunohistochemical phenotype diagnosed by biopsy and a mini-review of plasmacytoid features in the genitourinary system: A case report
Zacharouli K., Vageli D.P., Koukoulis G.K., Ioannou M. (2022)Prostate cancer is one of the most commonly diagnosed malignancies in men. Most of these tumors are adenocarcinomas. Plasmacytoid is a rare variant of adenocarcinoma described by previous studies in the genitourinary system ...